Sanofi is still plugging away with its oral BTK inhibitor tolebrutinib in multiple sclerosis, but has decided to abandon efforts to develop the drug for neuromuscular disorder myasthenia gravis.
In particular, the DLBCL variant represents the most common ... CLL/SLL patients may develop Richter transformation while on a BTK inhibitor, "the MOLTO regimen is particularly interesting as ...
The BTK inhibitors market has experienced significant dynamics driven by advancements in oncology and autoimmune disease treatments. One of the primary drivers of the BTK inhibitors market is the ...
GlobalData’s report assesses the drugs in the Tyrosine Protein Kinase BTK pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.
Discover what crypto is and how it works. A cryptocurrency is a digital form of money. They are digital assets created to be used to pay for goods and services. Cryptocurrencies can be used as a ...